Skip to main content

Table 2 Access to health care services among transgender women and transfeminine people in China, December 2019–June 2020 (N = 277)

From: Gender minority stress and access to health care services among transgender women and transfeminine people: results from a cross-sectional study in China

Health care services N (%)
Hormone intervention history  
 Have or currently undergoing 118 (42.6)
 Never 159 (57.4)
Gender affirming surgery  
 Have or currently undergoing 26 (9.4)
 Never 251 (90.6)
HIV testing  
 No 57 (20.6)
 Yes  
  Lifetime HIV testing 220 (79.4)
  Lifetime facility-based HIV testing 190 (86.4)
  Lifetime HIV self-testing 150 (68.5)
STIs testing in the past year  
 No 145 (52.3)
 Yes  
  Gonorrhea 23 (8.3)
  Chlamydia 15 (5.4)
  Syphilis 124 (44.8)
  HPV 33 (11.9)
  HSV2 8 (2.9)
PrEP use  
 Yes 24 (8.7)
 No 252 (91.3)
PEP use  
 Yes 29 (10.9)
 No 238 (89.1)
Living with HIV 20 (9.1)